TBPH Stock Summary and Trading Ideas (Theravance Biopharma - | NASDAQ:TBPH)

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Theravance Biopharma - trades on the NASDAQ stock market under the symbol TBPH.

As of March 6, 2026, TBPH stock price declined to $13.36 with 566,086 million shares trading.

TBPH has a beta of 0.97, meaning it tends to be less sensitive to market movements. TBPH has a correlation of 0.14 to the broad based SPY ETF.

TBPH has a market cap of $676.98 million. This is considered a Small Cap stock.

Last quarter Theravance Biopharma - reported $20 million in Revenue and $.07 earnings per share. This beat revenue expectation by $221,900 and exceeded earnings estimates by $.15.

In the last 3 years, TBPH traded as high as $21.03 and as low as $7.44.

The top ETF exchange traded funds that TBPH belongs to (by Net Assets): VTI, IWM, VXF, PBE, IBB.

TBPH has outperformed the market in the last year with a return of +37.4%, while the SPY ETF gained +16.6%. However, in the most recent history, TBPH shares have underperformed the stock market with its stock returning -28.0% in the last 3 month period and -31.2% for the last 2 week period, while SPY has returned -1.6% and -1.8%, respectively.

TBPH support price is $13.08 and resistance is $14.08 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TBPH shares will trade within this expected range on the day.